The Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, 1095 NW 14 Terrace, R48, Miami, FL 33136-2104, USA.
Brain. 2010 Jan;133(Pt 1):117-25. doi: 10.1093/brain/awp285. Epub 2009 Nov 10.
Baclofen, a gamma-aminobutyric acid receptor(B) agonist, is used to reduce symptoms of spasticity (hyperreflexia, increases in muscle tone, involuntary muscle activity), but the long-term effects of sustained baclofen use on skeletal muscle properties are unclear. The aim of our study was to evaluate whether baclofen use and paralysis due to cervical spinal cord injury change the contractile properties of human thenar motor units more than paralysis alone. Evoked electromyographic activity and force were recorded in response to intraneural stimulation of single motor axons to thenar motor units. Data from three groups of motor units were compared: 23 paralysed units from spinal cord injured subjects who take baclofen and have done so for a median of 7 years, 25 paralysed units from spinal cord injured subjects who do not take baclofen (median: 10 years) and 45 units from uninjured control subjects. Paralysed motor unit properties were independent of injury duration and level. With paralysis and baclofen, the median motor unit tetanic forces were significantly weaker, twitch half-relaxation times longer and half maximal forces reached at lower frequencies than for units from uninjured subjects. The median values for these same parameters after paralysis alone were comparable to control data. Axon conduction velocities differed across groups and were slowest for paralysed units from subjects who were not taking baclofen and fastest for units from the uninjured. Greater motor unit weakness with long-term baclofen use and paralysis will make the whole muscle weaker and more fatigable. Significantly more paralysed motor units need to be excited during patterned electrical stimulation to produce any given force over time. The short-term benefits of baclofen on spasticity (e.g. management of muscle spasms that may otherwise hinder movement or social interactions) therefore have to be considered in relation to its possible long-term effects on muscle rehabilitation. Restoring the strength and speed of paralysed muscles to pre-injury levels may require more extensive therapy when baclofen is used chronically.
巴氯芬是一种γ-氨基丁酸受体(B)激动剂,用于减轻痉挛症状(反射亢进、肌肉张力增加、不自主肌肉活动),但长期使用巴氯芬对骨骼肌特性的影响尚不清楚。我们的研究目的是评估巴氯芬的使用以及颈脊髓损伤引起的瘫痪是否比单纯瘫痪更能改变手部运动单位的收缩特性。通过对手部运动单位的单个运动轴突进行神经内刺激,记录诱发的肌电图活动和力。将三组运动单位的数据进行比较:23 个来自服用巴氯芬且中位数为 7 年的脊髓损伤受试者的瘫痪运动单位,25 个来自不服用巴氯芬(中位数:10 年)的脊髓损伤受试者的瘫痪运动单位,以及 45 个来自未受伤对照组的运动单位。瘫痪运动单位的特性与损伤时间和水平无关。在瘫痪和巴氯芬的作用下,中位运动单位强直力明显较弱,单次收缩半松弛时间较长,达到半最大力的频率较低,与未受伤的对照组相比。单独瘫痪后的这些相同参数的中位数值与对照数据相当。各组之间的轴突传导速度不同,未服用巴氯芬的受试者的瘫痪运动单位最慢,未受伤的运动单位最快。长期使用巴氯芬和瘫痪导致的运动单位无力程度更大,会使整个肌肉更弱,更容易疲劳。在一段时间内产生任何给定力时,需要兴奋更多的瘫痪运动单位。因此,在考虑巴氯芬对痉挛的短期益处(例如,管理可能会妨碍运动或社交互动的肌肉痉挛)时,必须考虑其对肌肉康复的可能长期影响。当长期使用巴氯芬时,要使瘫痪肌肉的强度和速度恢复到受伤前的水平,可能需要更广泛的治疗。